Endocrinology Conference cordially invites Researchers, physicians, Genomics associations and Public Healthcare Professionals from all over the globe to be present at “Endocrinology, Diabetes and other Health Care Disorders" which is going to be held during November 28-29, 2024 at Dubai, UAE. Endocrinology Conference based on the theme “Navigating Challenges, Enhancing Care and Redefining Wellness" is going to be an extraordinary event which will focus on the recent medical developments in the fields of Endocrinology, Diabetes and other Health Disorders.

Why join LONGDOM Conferences?

Understand the current state of research | Meet international colleagues and experts | Visit the exhibition of leading-edge technology | Engage with editors of the top journals in your field | Global networking and certification | Brand launching and many more to explore.

Who will be the participants?

Target Audience

Target audience are Physicians, Licensed Practical Nurse, Industry Professionals, Research Scholars, Healthcare Professionals Diagnostic laboratory professionals, Business Entrepreneurs, Directors & CEO’s of Organizations, Hospitals, Microbiologists, Pharmaceutical Industries, Nurse Practitioners.

Scientific Sessions

Session 1: Endocrinology and Types

Endocrinology is a branch of biology and medicine dealing with the endocrine system, the endocrine system is a network of glands that produce and release hormones. These hormones are in charge of several functions in the body, from heartbeat to tissue growth to the creation of new life. These glands that produce and release hormones that help control many important body functions, including the body's ability to change calories into energy that powers cells and organs.

Pediatric Endocrinology
Neuroendocrinology
Reproductive Endocrinology
Clinical Endocrinology
Cardiovascular Endocrinology

Session 2: Challenges in Endocrinology

The Endocrine system controls the stream of data amongst cells and tissues, represented by complex administrative components. Hormones apply across the board impacts on totally different metabolic procedures that guarantee administrative, transform genic and integrative capacity. Signs and indications of endocrine issue traverse the full clinical vary. Early conclusion and administration of endocrine ailments are fundamental and can be accomplished by the mix of focused endocrine testing, imaging, cautious history, physical examination and sound clinical judgment. Sufficient information and comprehension of fundamental science and standards of endocrinology are critical devices for the upgrade of productivity and accuracy‐goals of endocrine capacity testing. The ideal methodology for focused endocrine examination would accomplish the beliefs of achieving a particular conclusion in the most limited time, with least bother and cost on the patient.

Session 3: Advances in Endocrinology metabolism

Treat patients with hyperparathyroidism, Address particular issues of Graves' disease including thyrocardiac ailment, ophthalmopathy, dermopathy, delayed pregnancy, mammary, Use the 2015 ATA rules in the administration of their patients with thyroid knobs and thyroid malignancy determination, , Use the new lipid bringing operators and how down to oversee quiet who can't take statins. Intrinsic adrenal hyperplasia (CAH) are any of a few autosomal latent sicknesses coming about because of changes of qualities for catalysts intervening the biochemical strides of creation of mineralocorticoids, glucocorticoids or sex steroids from cholesterol by the endocrine organs (steroid beginning).

Session 4: Endocrine Emergencies

Endocrine emergencies encompass a spectrum of acute medical conditions that result from the dysregulation of hormones and endocrine organs. These emergencies require prompt recognition, diagnosis, and intervention to prevent serious complications and mitigate patient harm. One of the most common endocrine emergencies is diabetic ketoacidosis (DKA), a life-threatening complication of uncontrolled diabetes mellitus characterized by hyperglycemia, ketosis, and metabolic acidosis. DKA typically occurs in patients with type 1 diabetes but can also affect those with type 2 diabetes under certain circumstances, such as infection or inadequate insulin therapy.

Session 5: Updates in Endocrine surgery & Endocrine imaging

Updates in endocrine surgery and endocrine imaging have significantly influenced the diagnosis and management of various endocrine disorders, leading to improved patient outcomes and reduced surgical morbidity. In endocrine surgery, advancements in minimally invasive techniques have revolutionized the treatment of thyroid, parathyroid, and adrenal disorders. In endocrine imaging, technological innovations have expanded the armamentarium for non-invasive evaluation of endocrine disorders. High-resolution ultrasound remains a cornerstone for the assessment of thyroid nodules and parathyroid adenomas, providing detailed anatomical information and facilitating image-guided interventions.

Session 6: Environmental and Lifestyle Influences on Endocrine Health

Environmental and lifestyle factors profoundly impact endocrine health, influencing hormone regulation and the development of endocrine disorders. Exposure to endocrine-disrupting chemicals (EDCs) in everyday products poses additional risks to hormonal balance and reproductive health. Addressing these influences requires lifestyle modifications, including healthier dietary choices, regular exercise, sufficient sleep, and minimizing exposure to EDCs. By adopting these practices, individuals can support their endocrine health and reduce the risk of associated diseases.

Session 7: Diabetes, Types, symptoms and complications

Diabetes is brought about by the diminished creation of insulin or by a diminished capacity to utilize insulin. Insulin, the hormone delivered by the beta cells in the pancreas, permits (glucose) cells to have the capacity to utilize glucose. This hormone is fundamental for glucose to go from the blood to within the body cells. With deficient insulin, glucose develops in the circulatory system as opposed to going into the cells. The body can't utilize glucose for vitality in spite of the elevated amounts of glucose in the circulatory system.

Diabetes mellitus type 1
Diabetes mellitus type 2

Symptoms and Complications- The symptoms of diabetes can include increased thirst and hunger, frequent urination, fatigue, blurred vision, and slow healing of cuts and wounds. Over time, uncontrolled diabetes can lead to serious complications, such as heart disease, nerve damage, eye problems, kidney disease, and amputations. This conference provides a platform for experts in the field to share their knowledge and experience and to educate attendees about the latest advances in the management and treatment of diabetes.

Session 8: Advances in Diabetes Management

Advances in diabetes management have transformed treatment paradigms, offering personalized approaches and innovative therapies. Continuous glucose monitoring (CGM) systems provide real-time glucose data, optimizing glycemic control and reducing hypoglycemia. Novel medications, including GLP-1 receptor agonists and SGLT-2 inhibitors, offer cardiovascular benefits and weight loss, expanding treatment options. Closed-loop insulin delivery systems, or "artificial pancreas" technology, automate insulin delivery based on CGM data, enhancing glycemic stability. These advancements empower individuals with diabetes to achieve better glucose control, improve quality of life, and reduce the risk of long-term complications.

Session 9: Diabetes Research in Clinical Practice

Diabetes research and Novel remedial targets accessible for diabetes incorporates Incretion based treatments, oral helpful operators like secretagogues, cell recovery and growth and foundational organism treatments. Embryonic undeveloped cell and fetal antecedent cell transplantation treatments are the significant undifferentiated cell treatments accessible for Diabetes.

Session 10: Diabetic Disorders and Treatment

Diabetes, frequently referred to by specialists as diabetes mellitus, depicts a gathering of diabetes and metabolic sicknesses in which the individual has high blood (glucose), either in light of the fact that insulin generation is lacking, or on the grounds that the body's phones don't react appropriately to insulin, or both. Patients with high glucose will normally encounter polyuria (continuous pee), they will turn out to be progressively parched (polydipsia) and hungry (polyphagia). Recognizing type 1 and type 2 diabetes at determination is critical. Average qualities of type 2 diabetes incorporate the, Slow and guileful onset, most normal in overweight or fat patients from a minority bunch (Native Americans, blacks, and Pacific Islanders), Signs of insulin resistance, robust case history of kind a pair of diabetes. Familial way of life danger components prompting heftiness might be available, as may a family history of cardiovascular disease or metabolic disorder. Pediatric Diabetes is a type 1 diabetes mellitus requires insulin treatment.

Session 11: Technological Innovations in Diabetes Care

Technological innovations in diabetes care have revolutionized management strategies, providing new tools for monitoring and treatment. Continuous glucose monitoring (CGM) systems offer real-time glucose data, enhancing glycemic control and reducing hypoglycemia. Insulin pump therapy provides customizable insulin delivery, optimizing insulin dosing and flexibility. Advanced algorithms and software enable predictive analytics and personalized insulin dosing recommendations. Additionally, mobile applications and digital platforms facilitate self-management, education, and remote monitoring.

Session 12: Psychosocial Aspects of Diabetes

The psychosocial aspects of diabetes encompass the emotional, social, and behavioral factors that impact the well-being of individuals living with the condition. Diabetes distress, anxiety, depression, and stigma are common psychological challenges faced by patients, affecting self-care behaviors and quality of life. Social support networks, including family, friends, and healthcare providers, play a crucial role in coping and adjustment. Behavioural interventions, such as cognitive-behavioral therapy and motivational interviewing, help address psychological barriers and promote positive health behaviours. Recognizing and addressing the psychosocial dimensions of diabetes are essential for holistic care, improving mental health outcomes, and enhancing overall diabetes management.

Session 13: Insulin Action, Medication and its Mechanism

The Insulin Action session at this conference would likely focus on the molecular mechanisms of insulin action and the role of insulin in regulating metabolism. The Insulin Medication and its Mechanism in Diabetes session at a conference would likely focus on the use of insulin medication as a treatment for people with diabetes. Topics of discussion may include the different types of insulin medications available, their mechanisms of action, the factors that influence the choice of insulin medication, and the proper administration and dose of insulin. The goal of the session would be to provide attendees with a deeper understanding of insulin medication, its mechanisms of action, and the factors that influence its use in the treatment of diabetes.

Session 14: Genetics of Diabetes

A Genetics of diabetes session at this conference is a meeting of healthcare professionals, researchers, and individuals interested in the field of diabetes to discuss and share the latest developments, advancements, and research in the area of the genetics of diabetes. This session typically focuses on the genetic factors that contribute to the development of diabetes, including inheritance patterns, genetic mutations, and other genetic factors that increase the risk of diabetes.

Market Analysis

This conference serves as an invaluable platform for leading researchers, scholars, scientists, academicians, industry professionals, and PhD students in the field of endocrinology and diabetes to exchange knowledge about the latest scientific advancements. The global market for personalized medicine in endocrinology and diabetes is witnessing significant growth, with a projected value of USD 2,452.50 billion by 2022, driven by advancements such as next-generation sequencing, companion diagnostics, and the utilization of combination biomarkers. Factors such as the rising prevalence of endocrine disorders like diabetes, coupled with increasing healthcare expenditure, are fueling demand for effective diagnostic procedures and personalized treatment approaches. Additionally, the adoption of genetic mapping techniques and regulatory support for personalized medicine are expected to drive market growth. The introduction of novel drugs with companion diagnostics and the utilization of highly sensitive genetic diagnostic techniques further contribute to market expansion, facilitated by reduced implementation costs for whole genome sequencing. Overall, the conference provides a forum to explore these trends and their implications for advancing endocrinology and diabetes care.

Past Conference Report

Current and Future Trends in Endocrinology and Metabolomics 2020

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Current and Future Trends in Endocrinology and Metabolomics 2020 conference the best ever!

International conference on Current and Future Trends in Endocrinology and Metabolomics hosted by the Longdom Conference was held during June 18-19, 2020, Rome, Italy based on the theme “Innovation in the field of Endocrinology and Metabolomics”

The conference was initiated with the Honourable presence of the Keynote forum.

With the grand success of Current and Future Trends in Endocrinology and Metabolomics 2020, Longdom Conferences is proud to announce the " World Expo on Endocrinology, Diabetes and Health care disorders” to be held Nov 28-29, 2024 Dubai, UAE.

For More details, visit: https://www.longdom.com/endocrinology

International Conference on Diabetes and Endocrinology 2021

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making International Conference on Diabetes and Endocrinology 2021 conference the best ever!

International Conference on Diabetes and Endocrinology hosted by the Longdom Conference was held during Oct 29-30, 2021, Paris, France based on the theme “Late Advancements and Developments for Changing Life of Diabetes World”

The conference was initiated with the Honourable presence of the Keynote forum.

With the grand success of International Conference on Diabetes and Endocrinology 2021, Longdom Conferences is proud to announce the " World Expo on Endocrinology, Diabetes and Health care disorders” to be held Nov 28-29, 2024 Dubai, UAE.

For More details, visit: https://www.longdom.com/endocrinology

2nd International Conference on Diabetes and Endocrinology 2023

International Conference on Diabetes and Endocrinology hosted by the Longdom Conference was held during Aug 10- 12, 2021, Vienna, Austria based on the theme “Future of Diabetes Research and Clinical Practice”.

The conference was initiated with the Honourable presence of the Keynote forum.

With the grand success of International Conference on Diabetes and Endocrinology 2023, Longdom Conferences is proud to announce the " World Expo on Endocrinology, Diabetes and Health care disorders” to be held Nov 28-29, 2024 Dubai, UAE.

For More details, visit: https://www.longdom.com/endocrinology

Abstracts enquiry

Registration enquiry

Contact Enquiry

Phone

WhatsApp

Useful Links

News

Newsletter

About

Endocrinology, Diabetes and Health care disorders